Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michael B. Samuel"'
Outcomes of Cord Blood Vs Adult Stem Cell Sources in Patients with Mutated TP53 Myeloid Malignancies
Autor:
Nora Chokr, Dr. Joshua A Fein, Tsiporah B. Shore, Sebastian Mayer, Jingmei Hsu, Danielle Guarneri, Pinkal Desai, Adrienne A Phillips, Michael B. Samuel, Ellen K. Ritchie, Gail J. Roboz, Koen van Besien, Alexandra Gomez-Arteaga
Publikováno v:
Transplantation and Cellular Therapy. 29:S120-S121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e15cf7cc3ffa81b643660478e26e5f6
https://doi.org/10.1016/s2666-6367(23)00218-x
https://doi.org/10.1016/s2666-6367(23)00218-x
Autor:
Mateo Mejia Saldarriaga, Yassine Tahri, Sangmin Lee, Zhengming Chen, Tsiporah B. Shore, Danielle Guarneri, Sebastian Mayer, Adrienne A Phillips, Alexandra Gomez, Pinkal Desai, Ellen K. Ritchie, Michael B. Samuel, Gail J. Roboz, Koen van Besien, Jingmei Hsu
Publikováno v:
Transplantation and Cellular Therapy. 28:S432-S433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ecee84019d47062205f75f8835a171c
https://doi.org/10.1016/s2666-6367(22)00715-1
https://doi.org/10.1016/s2666-6367(22)00715-1
Autor:
Sangmin Lee, Michael S. Simon, Karla V. Ballman, Pinkal Desai, Michael B. Samuel, Duane C. Hassane, Gail J. Roboz, Oleksandr Savenkov, Monica L. Guzman, Ellen K. Ritchie, Nuria Mencia-Trinchant, Gloria Cheang
Publikováno v:
Nature Medicine. 24:1015-1023
The pattern of somatic mutations observed at diagnosis of acute myeloid leukemia (AML) has been well-characterized. However, the premalignant mutational landscape of AML and its impact on risk and time to diagnosis is unknown. Here we identified 212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5924b94827753287b7292acbe8823f07
https://doi.org/10.1038/s41591-018-0081-z
https://doi.org/10.1038/s41591-018-0081-z
Autor:
Xiaoyue Ma, Maximilian Stahl, Shira Dinner, Michael B. Samuel, Zoe McKinnell, Yazan Numan, Kendra Sweet, Akriti G Jain, Madelyn Burkart, Pinkal Desai, Paul J. Christos, Sangmin Lee, Justin D. Kaner, Gail J. Roboz, Christopher Famulare, Julian A. Waksal, Aaron D Goldberg, Justin Grenet, Ellen K. Ritchie, Brian Ball
Publikováno v:
Blood. 138:32-32
Background: Liposomal daunorubicin/cytarabine (CPX-351) and hypomethylating agent+venetoclax (HMA+V) have shown survival advantage as frontline therapies for older and biologically adverse AML. Although HMA+V is approved for chemotherapy ineligible p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05e5fd7b16c74df2bca14c93baa4bc2e
https://doi.org/10.1182/blood-2021-145947
https://doi.org/10.1182/blood-2021-145947
Autor:
Katarzyna Dulik, Agnieszka Wierzbowska, Damian Mikulski, Janusz Hałka, Krzysztof Wozniczka, Agnieszka Pluta, Tomasz Wróbel, Malgorzata Razny, Nuria Mencia-Trinchant, Andrzej Szczepaniak, Nicole M. Cruz, Agata Obara, Gail J. Roboz, Pinkal Desai, Sebastian Giebel, Michal Soin, Magdalena Dutka, Marta Sobas, Ellen K. Ritchie, Michael B. Samuel, Ewelina Perdas, Marek Hus, Justin D. Kaner, Maria Bieniaszewska, Lidia Gil, Wojciech Fendler, Piotr Stelmach, Edyta Cichocka, Anna Czyż, Marta Antonina Libura, Magdalena Czemerska, Elżbieta Patkowska, Monica L. Guzman, Jolanta Wozniak, Sangmin Lee, Agnieszka Kopacz, Tomasz Gromek, Jerzy Holowiecki, Anna Kopińska, Karol Wojcik, Grzegorz Helbig
Publikováno v:
Blood. 138:3453-3453
Background: Measurable residual disease (MRD) is an important biomarker in acute myeloid leukemia (AML). Among patients who achieve remission after standard chemotherapy, detection of MRD (MRD+) after two cycles of intensive chemotherapy, at the end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ef352f44355caa82b4601f6994b5ef8
https://doi.org/10.1182/blood-2021-153520
https://doi.org/10.1182/blood-2021-153520
Autor:
Sebastian Mayer, Mateo Mejia Saldarriaga, Jingmei Hsu, Pinkal Desai, Sangmin Lee, Koen van Besien, Alexandra Gomez-Arteaga, Yassine Tahri, Ellen K. Ritchie, Danielle Guarneri, Michael B. Samuel, Adrienne A. Phillips, Zhengming Chen, Gail J. Roboz, Tsiporah B. Shore
Publikováno v:
Blood. 138:4833-4833
Introduction: Acute myeloid leukemia (AML) is heterogenous disease with a range of cytogenetic and molecular changes. Several molecular mutations identified in AML patients at diagnosis have prognostic implications and play important roles in guiding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd1870e48e43ff590765467bd3fb0e23
https://doi.org/10.1182/blood-2021-149297
https://doi.org/10.1182/blood-2021-149297
Autor:
Agata Obara, Nuria Mencia-Trinchant, Marta Sobas, Michael B. Samuel, Grzegorz Helbig, Andrzej Szczepaniak, Piotr Stelmach, Anna Czyż, Ellen K. Ritchie, Jolanta Wozniak, Jerzy Holowiecki, Agnieszka Wierzbowska, Anna Kopińska, Nicole M. Cruz, Tomasz Wróbel, Magdalena Czemerska, Pinkal Desai, Tomasz Gromek, Sebastian Giebel, Elżbieta Patkowska, Alicja Sadowska-Klasa, Janusz Hałka, Michal Soin, Beata Blajer-Olszewska, Malgorzata Razny, Karol Wojcik, Justin D. Kaner, Jan Maciej Zaucha, Katarzyna Dulik, Lidia Gil, Edyta Cichocka, Krzysztof Wozniczka, Agnieszka Pluta, Marek Hus, Gail J. Roboz, Monica L. Guzman, Marta Antonina Libura, Sangmin Lee, Tadeusz Robak
Publikováno v:
Blood. 136:3-4
Background: AML is the most common acute leukemia in adults. While most adults < 60 years achieve complete remission (CR) with intensive induction chemotherapy, approximately one third have primary refractory disease and, overall, the majority of AML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a575eebb4fe87ad61a70674838ce604
https://doi.org/10.1182/blood-2020-140694
https://doi.org/10.1182/blood-2020-140694
Autor:
Karla V. Ballman, Nuria Mencia-Trinchant, Pinkal Desai, Monica L. Guzman, Sangmin Lee, Ellen K. Ritchie, Gail J. Roboz, Gloria Cheang, Michael S. Simon, Duane C. Hassane, Michael B. Samuel, Oleksandr Savenkov
BackgroundSomatic mutations observed in clonal hematopoiesis are associated with increased age and risk of hematological malignancies. However, the limited number of acute myeloid leukemia (AML) patients in studies of clonal hematopoiesis thus far ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb5d9118d06be226b61bbd393342a377
https://doi.org/10.1101/237941
https://doi.org/10.1101/237941
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Claire Douglass, Caroline M. Andy, Michael B. Samuel, Tania J. Curcio, Sumaiya Miah, Michael Hovan, Finola Goudy, Sangmin Lee, Pinkal Desai, Michael J. Satlin, Gail J. Roboz, Ellen K. Ritchie
Publikováno v:
Blood. 134:1336-1336
Background: Gastrointestinal dysbiosis has been associated with unfavorable clinical outcomes after allogeneic stem cell transplantation, but its clinical significance in patients receiving induction chemotherapy for AML has not been well defined. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e729fc346a44edc68be6e0984574698
https://doi.org/10.1182/blood-2019-125441
https://doi.org/10.1182/blood-2019-125441